易普利姆玛
无容量
医学
黑色素瘤
肿瘤科
内科学
免疫疗法
癌症研究
癌症
作者
Jedd D. Wolchok,Vanna Chiarion‐Sileni,Piotr Rutkowski,C. Lance Cowey,Dirk Schadendorf,John Wagstaff,Paola Queirolo,Reinhard Dummer,Marcus O. Butler,Andrew G. Hill,Michael A. Postow,C. Gaudy‐Marqueste,Theresa Medina,Christopher D. Lao,John R. Walker,Iván Márquez‐Rodas,John B.A.G. Haanen,Massimo Guidoboni,Michele Maio,Patrick Schöffski
标识
DOI：10.1056/nejmoa2407417
摘要
Previous results from this trial showed longer overall survival after treatment with nivolumab plus ipilimumab or with nivolumab monotherapy than with ipilimumab monotherapy in patients with advanced melanoma. Given that patients with advanced melanoma are living longer than 7.5 years, longer-term data were needed to address new clinically relevant questions.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
aldehyde
yydragen
江峰
哈基米德
乐乐乐乐乐乐
贰鸟
彭于彦祖
比比谁的速度快
Liufgui
灵巧的惜灵
二三
jyy
handa
SYLH
ICU最靓的崽
CAOHOU
iNk
脑洞疼
锂电打杂工
劈里啪啦小娇蛙
皖公网安备34019202002308
